Navigation Links
Loss of tumor-suppressor and DNA-maintenance proteins causes tissue demise
Date:10/15/2009

PHILADELPHIA - A study published in the October issue of Nature Genetics demonstrates that loss of the tumor-suppressor protein p53, coupled with elimination of the DNA-maintenance protein ATR, severely disrupts tissue maintenance in mice. As a result, tissues deteriorate rapidly, which is generally fatal in these animals. In addition, the study provides supportive evidence for the use of inhibitors of ATR in cancer therapy.

Essentially, says senior author Eric Brown, PhD, Assistant Professor of Cancer Biology at the University of Pennsylvania School of Medicine, the findings highlight the fact that day-to-day maintenance required to keep proliferative tissues like skin and intestines functional is about more than just regeneration, a stem cell-based process that forms the basis of tissue renewal. It's also about housekeeping, the clearing away of damaged cells.

Whereas loss of ATR causes DNA damage, the job of p53 is to monitor cells for such damage and either stimulate the early demise of such cells or prevent their replication, the housekeeping part of the equation. The findings indicate that as messy as things can become in the absence of a DNA maintenance protein like ATR, failing to remove resulting damaged cells by also deleting p53, is worse. "Because the persistence of damaged cells in the absence of p53 prevents appropriate tissue renewal, these and other studies have underscored the importance not only of maintaining competent stem cells, but also of eliminating what gets in the way of regeneration," explains Brown.

"An analogy to our findings is what happens to trees during the changing seasons," says Brown. "In springtime, leaves are new and undamaged. But as the summer wears on, the effects of various influences - insects, drought, and disease - cause them to lose the pristine qualities they once had. However, the subsequent fall of these leaves presents a unique opportunity for regeneration later on, a chance to rejuvenate from anew without pre-existing obstacles. Similarly, by suppressing the accumulation of damaged cells in tissues, p53 permits more efficient tissue renewal when ATR is deleted."

Cells without ATR that remain uncleared may be block tissue regeneration either by effectively refusing to relinquish space to undamaged cells, or by secreting signals that halt regeneration until they have been removed.

These results came as something of a surprise, says Brown. Previous studies pairing DNA-repair mutations with p53 mutations always led to a partial rescue of the DNA repair mutation "We think this happens because p53 loss helps cells with just a little DNA damage to continue to contribute to the tissue" says Brown. So at a minimum, the team expected nothing to happen.

"But we got the opposite result: Absence of p53 did not rescue the tissue degeneration caused by ATR loss, it made it much worse. This result suggested that allowing mutant cells without ATR to persist is more harmful to tissues than eliminating them in the first place." Brown speculates that could be because the ATR mutation produces much more damage than most other DNA-repair defects.

According to Brown, their findings and those of other laboratories also reinforce the potential of a new therapeutic for cancer. That's because, among their other discoveries, the team noticed that cells missing both ATR and p53 have more DNA damage than those missing either gene alone. As a large fraction of human cancers have p53 mutations, he says, "p53-deficient tumors might be especially susceptible to ATR inhibition." Indeed, clinical trials already are underway involving an ATR partner protein called Chk1. "Our study provides supportive evidence for the potential use of ATR/Chk1 inhibitors in cancer therapy," says Brown


'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Related medicine news :

1. Cold Spring Harbor science teams identify 13 new tumor-suppressor genes in liver cancer
2. Oncoproteins double-team and destroy vital tumor-suppressor
3. M. D. Anderson researchers identify tumor-suppressor gene for lung cancer
4. New findings about brain proteins suggest possible way to fight Alzheimers
5. Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins
6. New Antibiotics May Target Cancer-Causing Proteins
7. Brain Imaging (MRI/PET) and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis
8. Researchers identify key proteins needed for ovulation
9. Scripps research scientists model 3D structures of proteins that control human clock
10. Bioengineered proteins: Trial confirms new way to tackle cancer
11. Motor proteins may be vehicles for drug delivery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Loss of tumor-suppressor and DNA-maintenance proteins causes tissue demise
(Date:9/23/2017)... ... September 23, 2017 , ... “You Can't Win Them All”: ... in their business ventures and on the ice changed the lives of young athletes. ... Cosimo Filane was born and educated in Schreiber, a small town in Northern ...
(Date:9/22/2017)... ... September 22, 2017 , ... On Sunday, September 24, hundreds will gather at ... Joyner, still considered the fastest woman of all time. Flo Jo passed away ... will sing the National Anthem. Mary was a contestant on the 2012 season ...
(Date:9/22/2017)... ... September 22, 2017 , ... Fenwick Agency of Plano, ... communities they serve as part of the nationally recognized ‘Agents of Change’ movement. The ... nonprofit organizations and community leaders to seek out those who most need help. Their ...
(Date:9/22/2017)... ... September 22, 2017 , ... After ... a senior finds a new lease on life with assistance from CreditAssociates. CreditAssociates ... resolve their problem with unsecured debt. The senior is one of the satisfied ...
(Date:9/22/2017)... ... September 22, 2017 , ... SABRE ... Scholarship Sweepstakes.,  , Molli C., a graduate student from Sonora, California, who will ... Administration at St. Thomas University in Miami, Florida, was selected from a pool ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/5/2017)... Sept. 5, 2017 Sapheneia and Scannerside received ... Scannerside DoseCheck is a third-party Vendor neutral CT product ... and allows compliance with current MITA standards. ... 29 DoseCheck solution is specifically designed to provide CT ... potential radiation doses over a predefined threshold. Scannerside Dose ...
Breaking Medicine Technology: